DGKI and neoplasm: Addition of DGKi markedly increased cytotoxicity of C2VTrp1 and 6694c2 parental tumor cells, indicating that DGKi enhances cytotoxicity of effector CD8 T cells in conditions where antigen is limited (Fig. 2C).